|
NexMed Files NDS in Canada |
|
Written by Administrator
|
|
Monday, 22 October 2007 03:24 |
|
NexMed, Inc. , a developer of innovative transdermal products based on its proprietary NexACT drug delivery technology, today announced that it filed the New Drug Submission for its topical alprostadil ... via Business Wire
NexMed, Inc. , a developer of innovative transdermal products based on its proprietary NexACT drug delivery technology, today announced that it filed the New Drug Submission for its topical alprostadil ... via Business Wire
Read more at: . |
News 
